p33ING1 Antibodies

Santa Cruz Biotechnology provides a broad selection of p33ING1 monoclonal antibodies for research focused on understanding p33ING1 protein functions. Each monoclonal antibody has been validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p33ING1 plays a critical role in regulating cell cycle progression and apoptosis, making it an important factor in cancer research and cellular response to stress. p33ING1's involvement in chromatin remodeling and transcriptional regulation further highlights its significance in maintaining genomic stability. Research has shown that p33ING1 functions as a tumor suppressor, with altered expression levels observed in various cancer types. Understanding p33ING1 mechanisms can provide insights into tumorigenesis and potential therapeutic approaches. Ongoing studies continue to reveal new aspects of p33ING1's role in DNA repair and cellular aging processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of p33ING1 and its impact on human health and disease.